Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company 4SC AG
DescriptionOral inhibitor of kinesin spindle protein (KSP; Eg5; TRIP5)
Molecular Target Kinesin spindle protein (KSP) (Eg5) (KIF11)
Mechanism of ActionKinesin spindle protein inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
PartnerLink Health Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today